Lipid profile changes induced by glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Lipid profile changes induced by glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis

Published:2024-06-06 Issue:8 Volume:17 Page:721-729
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Chae Yuna¹,Kwon Sun-Hong¹²,Nam Jin Hyun³,Kang Eunsung¹,Im Jiae¹,Kim Hyo-Jin¹,Lee Eui-Kyung¹

Affiliation:

1. School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea

2. Sheffield Centre for Health and Related Research (SCHARR), School of Medicine and Population Health, University of Sheffield, Sheffield, UK

3. Division of Big Data Science, Korea University Sejong Campus, Sejong, Republic of Korea

Funder

SungKyunKwan University

Ministry of Education

National Research Foundation of Korea

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2024.2363838

Reference36 articles.

1. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017

2. Insights into incretin-based therapies for treatment of diabetic dyslipidemia

3. Cardiovascular Risk Factor Targets and Cardiovascular Disease Event Risk in Diabetes: A Pooling Project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study

4. Effects of Flywheel Training on Strength-Related Variables: a Meta-analysis

5. Liraglutide as add‐on to sodium‐glucose co‐transporter‐2 inhibitors in patients with inadequately controlled type 2 diabetes: LIRA‐ADD2SGLT2i, a 26‐week, randomized, double‐blind, placebo‐controlled trial

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic Changes Following Smoking Cessation in Patients with Type 2 Diabetes Mellitus;Biomedicines;2024-08-17